<html>
<head>PUBMED IDs for NR1F3</head>
<body bgcolor='#C5F0F2'><h1>NR1F3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/19965867/'>Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands.</a> May 12  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19965854/'>FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.</a> June 24  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19965850/'>Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis.</a> May 26  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19965845/'>The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy.</a> May 26  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19965803/'>FCGR2A functional genetic variant associated with susceptibility to severe malarial anaemia in Ghanaian children.</a> October 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19965795/'>Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study.</a> September 15  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19965785/'>Identification of two common variants contributing to serum apolipoprotein B levels in Mexicans.</a> February 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19965778/'>Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia.</a> February 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19965776/'>The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.</a> February 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20211758/'>A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol).</a> August 11  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/27186126/'>The therapeutic potential of RORγ modulators in the treatment of human disease.</a> January 1  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/27186126/'>The therapeutic potential of RORγ modulators in the treatment of human disease.</a> January 1  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23211525/'>Regulation of the human hydroxysteroid sulfotransferase (SULT2A1) by RORα and RORγ and its potential relevance to human liver diseases.</a> June 8  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/26048793/'>Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists.</a> March 10  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26321361/'>Identification of N-sulfonyl-tetrahydroquinolines as RORc inverse agonists.</a> May 24  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26321317/'>Genetic diversity of 15 autosomal STR loci in the population of Southern Punjab Pakistan.</a> July 19  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27879053/'>N-Arylsulfonyl Indolines as Retinoic Acid Receptor-Related Orphan Receptor γ (RORγ) Agonists.</a> November 24  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27879023/'>Potential effect of ezetimibe against Mycobacterium tuberculosis infection in type II diabetes.</a> November 24  2016<br></body></html>
